Navigation Links
New multi-use device can shed light on oxygen intake
Date:9/22/2009

WEST LAFAYETTE, Ind. - A fiber-optic sensor created by a team of Purdue University researchers that is capable of measuring oxygen intake rates could have broad applications ranging from plant root development to assessing the effectiveness of chemotherapy drugs.

The self-referencing optrode, developed in the lab of Marshall Porterfield, an associate professor of agricultural and biological engineering, is non-invasive, can deliver real-time data, holds a calibration for the sensor's lifetime and doesn't consume oxygen like traditional sensors that can compete with the sample being measured. A paper on the device was released on the early online version of the journal The Analyst this week.

"It's very sensitive in terms of the biological specimens we can monitor," Porterfield said. "We don't only measure oxygen concentration, we measure the flux. That's what's important for biologists."

Mohammad Rameez Chatni, a doctoral student in Porterfield's lab, said the sensor could be used broadly across disciplines. Testing included tumor cells, fish eggs, spinal cord material and plant roots.

Cancerous cells typically intake oxygen at higher rates than healthy cells, Chatni said. Measuring how a chemotherapy drug affects oxygen intake in both kinds of cells would tell a researcher whether the treatment was effective in killing tumors while leaving healthy cells unaffected.

Plant biologists might be interested in the sensor to measure oxygen intake of a genetically engineered plant's roots to determine its ability to survive in different types of soil.

"This tool could have applications in biomedical science, agriculture, material science. It's going across all disciplines," Chatni said.

The sensor is created by heating an optical fiber and pulling it apart to create two pointed optrodes about 15 microns in diameter, about one-tenth the size of a human hair. A membrane containing a fluorescent dye is placed on the tip of an optrode.

Oxygen binds to the fluorescent dye. When a blue light is passed through the optrode, the dye emits red light back. The complex analysis of that red light reveals the concentration of oxygen present at the tip of the optrode.

The optrode is oscillated between two points, one just above the surface of the sample and another a short distance away. Based on the difference in the oxygen concentrations, called flux, the amount of oxygen being taken in by the sample is calculated.

It's the intake, or oxygen transportation, that Porterfield said is important to understand.

"Just knowing the oxygen concentration in or around a sample will not necessarily correlate to the underlying biological processes going on," he said.

Porterfield said future work will focus on altering the device to measure things such as sodium and potassium intake as well. The National Science Foundation funded the research.


'/>"/>

Contact: Brian Wallheimer
bwallhei@purdue.edu
765-496-2050
Purdue University
Source:Eurekalert  

Related medicine news :

1. Cohera Medical Receives ISO 13485 Certification: Company Meets International Standards for Design, Development and Manufacturing of Medical Devices
2. New device could more effectively alleviate menstrual cramp pain
3. New device finds early signs of eye disease in preemies
4. FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices
5. Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australias Strategic Partnership
6. Medical Device Manufacturer MRPC Awarded ISO 13485 Certification
7. Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army
8. Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device
9. For Medical Device Makers, Free Webinar, Implementing QA Automation.
10. Sono-Tek Announces its Largest Ever Sales of MediCoat Stent Coating Systems to a Leading Global Medical Device Manufacturer
11. American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New multi-use device can shed light on oxygen intake
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: